Eradication of microscopic hepatic metastases by active specific immunization

Area of Science:

• Immunology
• Oncology
• Veterinary Medicine

Background:

• Hepatocellular carcinoma (HCC) poses a significant health challenge.
• Developing effective immunotherapies for liver cancer is a critical research area.
• Harnessing the host immune system against tumor cells is a promising therapeutic strategy.

Purpose of the Study:

• To evaluate the efficacy of active immunotherapy against experimental liver cancer in guinea pigs.
• To determine the essential components of the immunotherapy regimen.
• To assess the specificity of the induced anti-tumor immunity.

Main Methods:

• Guinea pigs with induced line 10 hepatocarcinoma liver deposits were immunized intradermally.
• Immunization involved a mixture of irradiated tumor cells and Bacillus Calmette-Guérin (BCG) cell wall emulsion (BCG CWE).
• Therapy was administered at specific time points post-tumor cell injection, and tumor growth, metastasis, and survival were monitored.

Main Results:

• Active immunization with irradiated line 10 tumor cells and BCG CWE significantly inhibited tumor outgrowth and metastasis.
• Both irradiated tumor cells and BCG CWE were essential for effective therapy.
• Immunization demonstrated specificity, as animals rejected line 10 tumor cells but not antigenically distinct line 1 tumor cells.

Conclusions:

• Combined active immunotherapy with irradiated tumor cells and BCG CWE is a viable treatment for experimental liver cancer.
• The immunotherapy induces specific anti-tumor immunity, capable of rejecting subsequent tumor challenges.
• This study highlights the potential of BCG-based immunotherapy in cancer treatment.